Donald P Lawrence

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 4

Top Topics

Basal Cell Carcinoma

Top Venues

Cancer research communications

This page only lists publications with an associated author ORCID identifier.

Publications

Elizabeth I Buchbinder, Justine V Cohen, Giuseppe Tarantino, Christine G Lian, David R Liu, Rizwan Haq, Frank Stephen Hodi, Donald P Lawrence, Anita Giobbie-Hurder, Deborah Knoerzer, Ryan J Sullivan
A Phase II Study of ERK Inhibition by Ulixertinib (BVD-523) in Metastatic Uveal Melanoma. Cancer research communications 4 (5) (2024)
Elizabeth I Buchbinder, Justine V Cohen, Giuseppe Tarantino, Christine G Lian, David R Liu, Rizwan Haq, Frank Stephen Hodi, Donald P Lawrence, Anita Giobbie-Hurder, Deborah Knoerzer, Ryan J Sullivan
A Phase II study of ERK inhibition by ulixertinib (BVD-523) in Metastatic Uveal Melanoma. Cancer research communications (2024)
Elizabeth I Buchbinder, Justine V Cohen, Giuseppe Tarantino, Christine G Lian, David R Liu, Rizwan Haq, Frank Stephen Hodi, Donald P Lawrence, Anita Giobbie-Hurder, Deborah Knoerzer, Ryan J Sullivan
A Phase II study of ERK inhibition by ulixertinib (BVD-523) in Metastatic Uveal Melanoma. Cancer research communications (2024)
Elizabeth I Buchbinder, Justine V Cohen, Giuseppe Tarantino, Christine G Lian, David R Liu, Rizwan Haq, Frank Stephen Hodi, Donald P Lawrence, Anita Giobbie-Hurder, Deborah Knoerzer, Ryan J Sullivan
A Phase II Study of ERK Inhibition by Ulixertinib (BVD-523) in Metastatic Uveal Melanoma. Cancer research communications 4 (5) (2024)